Piramal Pharma informs about grant of stock options

26 Jul 2024 Evaluate

Pursuant to Regulation 30 read with Schedule III to the SEBI Listing Regulations, Piramal Pharma has informed that the Nomination and Remuneration Committee of the Board of Directors of the Company at its meeting held on Friday, 26th July, 2024 approved grant of 4,830,836 stock options under the Plan 2022. The disclosure as required under Regulation 30 of SEBI Listing Regulations is enclosed as Annexure-1.

The above information is a part of company’s filings submitted to BSE.


Piramal Pharma Share Price

179.95 -0.60 (-0.33%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×